184 related articles for article (PubMed ID: 16920559)
1. Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).
Castilla C; Pérez-Simón JA; Sanchez-Guijo FM; Díez-Campelo M; Ocio E; Pérez-Persona E; López-Villar O; Vazquez L; Caballero D; San Miguel JF
Biol Blood Marrow Transplant; 2006 Sep; 12(9):936-41. PubMed ID: 16920559
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.
Iyer RV; Hahn T; Roy HN; Battiwalla M; Cooper M; Anderson B; Paplham P; Brown K; Bambach B; Segal BH; McCarthy PL
Biol Blood Marrow Transplant; 2005 Aug; 11(8):587-92. PubMed ID: 16041308
[TBL] [Abstract][Full Text] [Related]
3. Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease.
Villanueva FN; Pérez-Simón JA; Silva FF; Caballero-Velázquez TT; Sánchez-Guijo FF; Cañizo CC; Vázquez LL; Caballero DD; San Miguel JF
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1331-6. PubMed ID: 19747642
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of blood concentrations following oral administration of beclomethasone dipropionate for gut GVHD].
Ito T; Watanabe K; Nasu I; Ino K; Minowa M; Furusawa M; Okuno Y; Uchida Y; Miyazaki Y; Tamura H; Hasebe S; Takagi S; Yamamoto H; Matsuno N; Uchida N; Masuoka K; Wake A; Makino S; Taniguchi S; Hayashi M
Gan To Kagaku Ryoho; 2010 Feb; 37(2):267-70. PubMed ID: 20154483
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.
Kobbe G; Schneider P; Rohr U; Fenk R; Neumann F; Aivado M; Dietze L; Kronenwett R; Hünerlitürkoglu A; Haas R
Bone Marrow Transplant; 2001 Jul; 28(1):47-9. PubMed ID: 11498743
[TBL] [Abstract][Full Text] [Related]
7. Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD.
Andree H; Hilgendorf I; Leithaeuser M; Junghanss C; Holzhueter S; Loddenkemper C; Steiner B; Freund M; Wolff D
Bone Marrow Transplant; 2008 Oct; 42(8):541-6. PubMed ID: 18641680
[TBL] [Abstract][Full Text] [Related]
8. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease.
Baehr PH; Levine DS; Bouvier ME; Hockenbery DM; Gooley TA; Stern JG; Martin PJ; McDonald GB
Transplantation; 1995 Dec; 60(11):1231-8. PubMed ID: 8525516
[TBL] [Abstract][Full Text] [Related]
9. Oral beclomethasone dipropionate as an initial treatment for stages 1-2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation.
Yamamoto H; Uchida N; Uchida Y; Nishida A; Ota H; Kageyama K; Nasu I; Wada S; Kaji D; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Matsuno N; Yamamoto G; Masuoka K; Izutsu K; Wake A; Yoneyama A; Makino S; Ito T; Hayashi M; Taniguchi S
Ann Hematol; 2015 Dec; 94(12):2073-5. PubMed ID: 26374433
[No Abstract] [Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
Hockenbery DM; Cruickshank S; Rodell TC; Gooley T; Schuening F; Rowley S; David D; Brunvand M; Berryman B; Abhyankar S; Bouvier M; McDonald GB
Blood; 2007 May; 109(10):4557-63. PubMed ID: 17244684
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
Huff CA; Fuchs EJ; Smith BD; Blackford A; Garrett-Mayer E; Brodsky RA; Flinn IW; Ambinder RF; Borrello IM; Matsui WH; Vogelsang GB; Griffin CA; Luznik L; Jones RJ
Biol Blood Marrow Transplant; 2006 Apr; 12(4):414-21. PubMed ID: 16545725
[TBL] [Abstract][Full Text] [Related]
13. Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.
Wolff D; Wilhelm S; Hahn J; Gentilini C; Hilgendorf I; Steiner B; Kahl C; Junghanss C; Hartung G; Casper J; Uharek L; Holler E; Freund M
Bone Marrow Transplant; 2006 Sep; 38(6):445-51. PubMed ID: 16951692
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD.
Bertz H; Afting M; Kreisel W; Duffner U; Greinwald R; Finke J
Bone Marrow Transplant; 1999 Dec; 24(11):1185-9. PubMed ID: 10642806
[TBL] [Abstract][Full Text] [Related]
15. Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation.
McDonald GB
Expert Opin Investig Drugs; 2007 Oct; 16(10):1709-24. PubMed ID: 17922633
[TBL] [Abstract][Full Text] [Related]
16. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
17. Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation.
Miura Y; Narimatsu H; Kami M; Kusumi E; Matsumura T; Yuji K; Wake A; Miyakoshi S; Taniguchi S
Bone Marrow Transplant; 2006 Oct; 38(8):577-9. PubMed ID: 16953206
[No Abstract] [Full Text] [Related]
18. First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate.
Wang Y; Xu LP; Liu DH; Chen H; Chen YH; Han W; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2009 Apr; 15(4):505-11. PubMed ID: 19285639
[TBL] [Abstract][Full Text] [Related]
19. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
20. Beclometasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease.
Díez-Campelo M; Sánchez-Guijo FM; Pérez-Simón JA
Expert Opin Investig Drugs; 2008 Sep; 17(9):1389-401. PubMed ID: 18694371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
